scispace - formally typeset
A

Andrew Farb

Researcher at Food and Drug Administration

Publications -  192
Citations -  36289

Andrew Farb is an academic researcher from Food and Drug Administration. The author has contributed to research in topics: Restenosis & Stent. The author has an hindex of 68, co-authored 183 publications receiving 33647 citations. Previous affiliations of Andrew Farb include Center for Drug Evaluation and Research & Northwestern University.

Papers
More filters
Journal ArticleDOI

Lessons From Sudden Coronary Death A Comprehensive Morphological Classification Scheme for Atherosclerotic Lesions

TL;DR: This review will reconsider the current paradigm for understanding the critical, final steps in the progression of atherosclerotic lesions, and devise a simpler classification scheme that is consistent with the AHA categories but is easier to use, able to deal with a wide array of morphological variations, and not overly burdened by mechanistic implications.
Journal ArticleDOI

From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II.

Morteza Naghavi, +63 more
- 07 Oct 2003 - 
TL;DR: The term "vulnerable patient" may be more appropriate and is proposed now for the identification of subjects with high likelihood of developing cardiac events in the near future and a quantitative method for cumulative risk assessment of vulnerable patients needs to be developed.
Journal ArticleDOI

Pathology of Drug-Eluting Stents in Humans: Delayed Healing and Late Thrombotic Risk

TL;DR: The Cypher and Taxus DES result in delayed arterial healing when compared with BMS of similar implant duration, and the cause of DES LST is multifactorial with delayed healing in combination with other clinical and procedural risk factors playing a role.
Journal ArticleDOI

Pathology of the Vulnerable Plaque

TL;DR: Of the three types of coronary thrombosis, a precursor lesion for acute rupture has been postulated and the non-thrombosed lesion that most resembles the acute plaque rupture is the thin cap fibroatheroma (TCFA).
Journal ArticleDOI

Coronary Risk Factors and Plaque Morphology in Men with Coronary Disease Who Died Suddenly

TL;DR: Among men with coronary disease who die suddenly, abnormal serum cholesterol concentrations - particularly elevated ratios of total cholesterol to HDL cholesterol - predispose patients to rupture of vulnerable plaques, whereas cigarette smoking predisposes patients to acute thrombosis.